Kerstin Folkerts, MSc

home / authors / kerstin-folkerts-msc

Articles

August 16th 2022

Validation of the FINE-CKD Model for Future Health Technology Assessments for Finerenone in Patients With Chronic Kidney Disease And Type 2 Diabetes

Michał Pochopień, MSc David Z. I. Cherney, MD, PhD Aleksandra Drzewiecka, MSc Kerstin Folkerts, MSc Pierre Levy, PhD Aurélie Millier, PhD Stephen Morris, PhD Monika Palarczyk, MSc Prabir Roy-Chaudhury, MD, PhD Sean D. Sullivan, PhD Paul Mernagh, MCom

December 8th 2021

ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

Linda F. Fried, MD, MPH Natalia Petruski-Ivleva, PhD Kerstin Folkerts, MSc Niklas Schmedt, DrPH Priscilla Velentgas, PhD Csaba P. Kovesdy, MD

December 8th 2021

FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Michał Pochopień, MSc David Z. I. Cherney, MD, PhD Kerstin Folkerts, MSc Pierre Levy, PhD Aurélie Millier, PhD Stephen Morris, PhD Prabir Roy-Chaudhury, MD, PhD Sean D. Sullivan, PhD Paul Mernagh, MCom

December 8th 2021

eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease

Linda F. Fried, MD, MPH Natalia Petruski-Ivleva, PhD Kerstin Folkerts, MSc Niklas Schmedt, DrPH Priscilla Velentgas, PhD Csaba P. Kovesdy, MD

December 8th 2021

eAppendix: FINE-CKD Model to Evaluate Economic Value of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes

Michał Pochopień, MSc David Z. I. Cherney, MD, PhD Kerstin Folkerts, MSc Pierre Levy, PhD Aurélie Millier, PhD Stephen Morris, PhD Prabir Roy-Chaudhury, MD, PhD Sean D. Sullivan, PhD Paul Mernagh, MCom

May 11th 2021

Targeted Literature Review of the Burden of Illness in Patients With Chronic Kidney Disease and Type 2 Diabetes

Linda F. Fried, MD, MPH Kerstin Folkerts, MSc Beata Smela, MSc Kevin Deon Bowrin, MSc Paul Mernagh, MCom Aurelie Millier, PhD Csaba P. Kovesdy, MD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Glaucoma | Image credit: Alessandro Grandini - stock.adobe.com

Published: November 21st 2024 | Updated: November 24th 2024

Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions